Mass spectrometry in the clinical laboratory. A short journey through the contribution to the scientific literature by CCLM

Clin Chem Lab Med. 2022 Oct 26;61(5):873-879. doi: 10.1515/cclm-2022-0984. Print 2023 Apr 25.

Abstract

Mass spectrometry (MS) has been a gold standard in the clinical laboratory for decades. Although historically refined to limited areas of study such as neonatal screening and steroid analysis, technological advancements in the field have resulted in MS becoming more powerful, versatile, and user-friendly than ever before. As such, the potential for the technique in clinical chemistry has exploded. The past two decades have seen advancements in biomarker detection for disease diagnostics, new methods for protein measurement, improved methodologies for reliable therapeutic drug monitoring, and novel technologies for automation and high throughput. Throughout this time, Clinical Chemistry and Laboratory Medicine has embraced the rapidly developing field of mass spectrometry, endeavoring to highlight the latest techniques and applications that have the potential to revolutionize clinical testing. This mini review will highlight a selection of these critical contributions to the field.

Keywords: GC-MS; LC-MS; mass spectrometry.

Publication types

  • Review

MeSH terms

  • Clinical Laboratory Services*
  • Drug Monitoring
  • Humans
  • Infant, Newborn
  • Laboratories, Clinical*
  • Mass Spectrometry / methods
  • Neonatal Screening